Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome
ABSTRACT Systemic inflammatory response syndrome (SIRS) is a severe inflammatory response that can lead to organ dysfunction and death. Modulating the gut microbiome is a promising therapeutic approach for managing SIRS. This study assesses the therapeutic potential of the Xuanfei Baidu (XFBD) formu...
Saved in:
| Main Authors: | Luyao Liu, Lin Ma, Huan Liu, Fan Zhao, Pu Li, Junhua Zhang, Xin Lü, Xin Zhao, Yanglei Yi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2024-10-01
|
| Series: | mSystems |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/msystems.00788-24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The gut microbiome and osteoarthritis
by: Wiktoria Maria Krupka, et al.
Published: (2025-02-01) -
Gut Microbiome in Pulmonary Arterial Hypertension—An Emerging Frontier
by: Sasha Z. Prisco, et al.
Published: (2025-06-01) -
Relationship between the gut microbiome and the development of colorectal cancer
by: Yang-Ting HE, et al.
Published: (2020-12-01) -
Gut Microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients
by: Paula L. Scalzo, et al.
Published: (2025-03-01) -
Effect of melatonin on gut microbiome and metabolomics in diabetic cognitive impairment
by: Ming Gao, et al.
Published: (2024-11-01)